IGC Pharma (IGC) Minority Interest (2011 - 2017)
IGC Pharma (IGC) reported Minority Interest of -$9007.0 for Q4 2017, little changed year-over-year from -$9014.0 in Q4 2016, and down 1.73% quarter-over-quarter from -$8854.0 in Q3 2017.
IGC Pharma (IGC) Minority Interest (2011 - 2017) Analysis & Trends
IGC Pharma (IGC) has 7 years of Minority Interest data on file, last reported at -$9007.0 in Q4 2017.
- Minority Interest for Q4 2017 came in at -$9007.0, changed 0.08% year-over-year; the trailing twelve-month figure through Dec 2017 was -$9007.0 (changed 0.08% YoY), and the FY2017 annual result was -$8836.0, down 101.87% from the prior year.
- Minority Interest fell to -$9007.0 in Q4 2017 per IGC's latest filing, from -$8854.0 in the prior quarter.
- Over five years, Minority Interest peaked at $576803.0 in Q2 2014 and troughed at -$9007.0 in Q4 2017.
- A 5-year average of $393083.6 and a median of $523033.0 in 2014 frame the typical range for Minority Interest.
- The sharpest annual moves came in 2014 and 2017: Minority Interest advanced 6.96% in 2014, then plunged 102.1% in 2017.
- A 5-year view of Minority Interest shows it stood at $531772.0 in 2013, then grew by 4.67% to $556612.0 in 2014, then climbed by 2.35% to $569702.0 in 2015, then slumped by 101.58% to -$9000.0 in 2016, then slipped by 0.08% to -$9007.0 in 2017.
- Business Quant data shows IGC's Minority Interest at -$9007.0 in Q4 2017, -$8854.0 in Q3 2017, and -$8790.0 in Q2 2017.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - |
| 10 | IGC Pharma | 29.33 Mn | 29.07 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2017 | -9,007.00 |
| Sep 30, 2017 | -8,854.00 |
| Jun 30, 2017 | -8,790.00 |
| Mar 31, 2017 | -8,836.00 |
| Dec 31, 2016 | -9,000.00 |
| Sep 30, 2016 | 420,633.00 |
| Jun 30, 2016 | 490,794.00 |
| Mar 31, 2016 | 472,057.00 |
| Dec 31, 2015 | 569,702.00 |
| Sep 30, 2015 | 527,954.00 |
| Jun 30, 2015 | 544,605.00 |
| Mar 31, 2015 | 515,927.00 |
| Dec 31, 2014 | 556,612.00 |
| Sep 30, 2014 | 564,722.00 |
| Jun 30, 2014 | 576,803.00 |
| Mar 31, 2014 | 518,112.00 |
| Dec 31, 2013 | 531,772.00 |
| Sep 30, 2013 | 539,092.00 |
| Jun 30, 2013 | 539,273.00 |
| Mar 31, 2013 | 538,100.00 |